Results 121 to 130 of about 34,432 (188)

Assessing the effect of remdesivir alone and in combination with corticosteroids on time to death in COVID-19: A propensity score-matched analysis

Journal of Clinical Virology Plus
Background: This study aimed to evaluate the impact of remdesivir, alone or in combination with corticosteroids, on the time to death in COVID-19 patients. Methods: This retrospective cohort study was conducted between March 20, 2020, and March 18, 2021,
Mohamad Amin Pourhoseingholi, Mehdi Azizmohammad Looha, Saba Ilkhani, Hamidreza Hatamabadi, Amir Sadeghi, Seyed Amir Ahmad Safavi-Naini, Kamran Heidari, Nazanin Taraghikhah, Mohammad Mahdi Fallah, Reyhaneh Kalantar, Nariman Naderi, Romina Esbati, Nastaran Ebrahimi, Ali Solhpour, Tannaz Jamialahmadi, Amirhossein Sahebkar   +15 more
doaj  

Research note: Antiviral effect of remdesivir against experimental Newcastle disease virus infection in chickens. [PDF]

Poult Sci
Dyary HO.
europepmc   +1 more source

Rapid determination of remdesivir (SARS-CoV-2 drug) in human plasma for therapeutic drug monitoring in COVID-19-Patients

, 2020
Raghavendra Rao Pasupuleti, Pei‐Chien Tsai, Vinoth Kumar Ponnusamy, Arivalagan Pugazhendhi   +3 more
openalex   +1 more source

A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19 [PDF]

, 2020
Dawid Maciorowski, Samir Z. El Idrissi, Yash Gupta, Brian Medernach, Michael B. Burns, Daniel P. Becker, Ravi Durvasula, Prakasha Kempaiah   +7 more
openalex   +1 more source

Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients. [PDF]

PNAS Nexus
Iriyama C, Ichikawa T, Tamura T, Takahata M, Ishio T, Ibata M, Kawai R, Iwata M, Suzuki M, Adachi H, Nao N, Suzuki H, Kawai A, Kamiyama A, Suzuki T, Hirata Y, Iida S, Katano H, Ishii Y, Tsuji T, Oda Y, Tanaka S, Okazaki N, Katayama Y, Nakagawa S, Tsukamoto T, Doi Y, Fukuhara T, Murata T, Tomita A.   +29 more
europepmc   +1 more source

Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated. [PDF]

Children (Basel)
Nieves DJ, Tran MT, Singh J, Ashouri N, Morphew T, Lusk JG, Adler-Shohet FC, Marano R, Osborne S, Strickland J, Arrieta AC.   +10 more
europepmc   +1 more source

Compassionate use of remdesivir for treatment of severe coronavirus disease 2019 in pregnant women at a United States academic center

, 2020
Jennifer A. McCoy, William R. Short, Sindhu K. Srinivas, Lisa D. Levine, Adi Hirshberg   +4 more
openalex   +1 more source

Public Risk-Taking and Rewards During the COVID-19 Pandemic - A Case Study of Remdesivir in the Context of Global Health Equity [PDF]

, 2020
Sabrina Wimmer, Sarai Keestra
openalex   +1 more source

Remdesivir associated with reduced mortality in hospitalized COVID-19 patients: treatment effectiveness using real-world data and natural language processing. [PDF]

BMC Infect Dis
Arribas López JR, Ruiz Seco MP, Fanjul F, Díaz Pollán B, González Ruano Pérez P, Ferre Beltrán A, De Miguel Buckley R, Portillo Horcajada L, De Álvaro Pérez C, Barroso Santos Carvalho PJ, Savana Research Group, Riera Jaume M.   +11 more
europepmc   +1 more source

Toward Secure Supply of Remdesivir via a 2-Pot Triazine Synthesis: Supply Centered Synthesis [PDF]

, 2020
Dinesh J. Paymode, Flavio S. P. Cardoso, Joshua D. Sieber, John W. Tomlin, Daniel W. Cook, Justina M. Burns, Rodger W. Stringham, B. Frank Gupton, David R. Snead, Toolika Agrawal   +9 more
openalex   +1 more source